Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia
Leukemias arise from genetic alterations in normal hematopoietic stem or progenitor cells, leading to impaired regulation of proliferation, differentiation, apoptosis, and survival of the transformed cells. With the advent of RNA interference (RNAi) and the short interfering RNA (siRNA) as its pharm...
Saved in:
Main Authors: | Breanne Landry (Author), Juliana Valencia-Serna (Author), Hilal Gul-Uludag (Author), Xiaoyan Jiang (Author), Anna Janowska-Wieczorek (Author), Joseph Brandwein (Author), Hasan Uludag (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
by: Tatiana I Novobrantseva, et al.
Published: (2012) -
Achieving efficient RNAi therapy: progress and challenges
by: Kun Gao, et al.
Published: (2013) -
Molecular landscape and targeted therapy of acute myeloid leukemia
by: Runxia Gu, et al.
Published: (2018) -
Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia
by: Pourrajab F, et al.
Published: (2020) -
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
by: Xiaoyan Liu, et al.
Published: (2019)